Operating income before deduction of amortization: NRx Pharmaceuticals Inc. (NRXP)

NRx Pharmaceuticals develops proprietary methods to combat suicidal depression, maintaining a high reputation among scientists. The EBITDA financial metric illustrates the business's operational resilience, where 0.00 is the current value of the indicator. Stable demand for psychopharmacology during any crisis makes the company's success dependent solely on regulatory approvals and clinical trial results.

NRx Pharmaceuticals (NRXP) Operating profit EBITDA: for the period 11/23/2025 - 11/15/2026

Summary analytical data breakdowns for nrxpharma.com (NRXP)

- share price and consensus valuation forecast:

Quote Chart nrxpharma.com|NRXP - Price Target Chart

- company stock exchange capitalization indicators:

Market Capitalization NRx Pharma|NRXP - Real Price to Acquire Entire Company

- balance sheet equity data:

Net Asset Value per Share NRx Pharmaceuticals|NRXP - Book Capitalization|Market Cap to Net Assets Ratio nrxpharma.com|NRXP - Company Total Assets

- company total debt and liquidity indicators:

All Debt to Shareholders' Equity Ratio NRx Pharmaceuticals|NRXP - Long-Term Debt to Equity|Current Liabilities to Capital NRx Pharmaceuticals, Inc|NRXP - Company Debts|Debt to Book Value Ratio NRx Pharmaceuticals Inc.|NRXP - Company Long-Term Debt|Company Short-Term Loans and Borrowings NRx Pharmaceuticals|Immediate Liquidity Ratio nrxpharma.com

- earnings and market multiples details:

NRXP - Net Income|Expected Net Income NRx Pharmaceuticals|NRXP - Price to Earnings Ratio|Price to Expected Earnings Ratio NRx Pharmaceuticals, Inc.|NRXP - PEG Multiple|Business Value to Operating Income Before Depreciation NRx Pharmaceuticals, Inc.|NRXP - Operating profit EBITDA|Net earnings per share (EPS TTM) NRx Pharmaceuticals|NRXP - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months nrxpharma.com|NRXP - Earnings per share growth in current year|Expected earnings per share growth for next year NRx Pharmaceuticals

- sales revenue and business income indicators:

NRXP - Revenue and Sales Volume|Projected Sales Volume NRx Pharmaceuticals|NRXP - P/S Multiple|Forward Price-to-Revenue Multiple NRx Pharmaceuticals, Inc.

Analysis of all company metrics:nrxpharma.com - NRXP

NRx Pharmaceuticals' development of therapies for suicidal depression and the pending approval of NRX-101 determine the expenditure structure, which directly impacts the level of net operating income before depreciation. This indicator captures the actual cash flow from core operations excluding amortization, allowing for an assessment of the business's financial viability during a recession and the mitigation of capital freeze risks.

Competitors of NRx Pharmaceuticals (NRXP)